From: Safety and efficacy of platelet-rich plasma in treatment of carpal tunnel syndrome; a randomized controlled trial
Group
Condition
Normal
N(%)
Mild
Moderate
Control
Before
0(0%)
15 (75%)
5 (25%)
After
16 (80%)
14 (20%)
Treat
12 (57%)
9(43%)
3(14%)
10(48%)
8 (38%)